I've said it before and I will say it again: When the United States' best scientists and our partner innovators bring their ingenuity and innovation together, anything is possible. I'm excited to see what this partnership brings to bear to help fight #COVID19. https://t.co/akjvdeelDh
— Secretary Pompeo (@SecPompeo) May 1, 2020
In a tweet on April 28, Reifman had said: "Great to see #Hyderabad advancing solutions in the global fight against COVID-19. US-India partnership is integral to our shared success, partnerships like @BharatBiotech collaborating with virologists at University of Wisconsin-Madison on vaccine development. #DostiUnitesUs."
The Consul General's tweet contained what appeared to be a snapshot of a twitter interaction between KTR, Minister for Information Technology, Telangana and Amitabh Kant, CEO, Niti Aayog.
On April 20, Kant had tweeted: "The six Indian companies in race to make the 1st Covid vaccine. India is the epicentre for vaccine manufacturing in the world. India has emerged as the global vaccines hub. We must crack this to enable the world to get vaccine at low price points and make world Covid free." He had also attached an image to his tweet.
Re-tweeting this, KTR said: "Feels great to note that 3 out of the 6 companies are Hyderabad headquartered. As it is, Hyderabad currently produces 1/3rd of human vaccines for the world."
Earlier too, laying emphasis on India-US cooperation to tackle the coronavirus and its impact, Pompeo had said that Trump administration is working with countries like Australia, India, Japan among others to share best practices and information.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.